News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
254,491 Results
Type
Article (11721)
Company Profile (38)
Press Release (242732)
Multimedia
Podcasts (31)
Webinars (9)
Section
Business (89950)
Career Advice (274)
Deals (14999)
Drug Delivery (46)
Drug Development (27297)
Employer Resources (49)
FDA (4700)
Job Trends (6387)
News (135814)
Policy (9756)
Tag
Academia (1106)
Accelerated approval (2)
Adcomms (1)
Allergies (28)
Alliances (34055)
ALS (42)
Alzheimer's disease (559)
Antibody-drug conjugate (ADC) (87)
Approvals (4743)
Artificial intelligence (163)
Autoimmune disease (16)
Automation (10)
Bankruptcy (143)
Best Places to Work (5433)
BIOSECURE Act (10)
Biosimilars (53)
Biotechnology (33)
Bladder cancer (23)
Brain cancer (13)
Breast cancer (114)
Cancer (1018)
Cardiovascular disease (65)
Career advice (229)
Career pathing (11)
CAR-T (73)
Cell therapy (235)
Cervical cancer (12)
Clinical research (22291)
Collaboration (723)
Compensation (85)
Complete response letters (6)
COVID-19 (1036)
CRISPR (28)
C-suite (144)
Cystic fibrosis (43)
Data (769)
Decentralized trials (2)
Denatured (18)
Depression (23)
Diabetes (84)
Diagnostics (2704)
Digital health (11)
Diversity (8)
Diversity, equity & inclusion (15)
Drug discovery (76)
Drug pricing (31)
Drug shortages (6)
Duchenne muscular dystrophy (42)
Earnings (26076)
Editorial (12)
Employer branding (3)
Employer resources (46)
Events (34736)
Executive appointments (408)
FDA (5194)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (535)
Gene editing (61)
Generative AI (14)
Gene therapy (171)
GLP-1 (251)
Government (1567)
Guidances (26)
Healthcare (8260)
Huntington's disease (9)
IgA nephropathy (11)
Immunology and inflammation (74)
Indications (8)
Infectious disease (1107)
Inflammatory bowel disease (60)
Inflation Reduction Act (7)
Influenza (33)
Intellectual property (51)
Interviews (23)
IPO (6424)
IRA (13)
Job creations (1137)
Job search strategy (197)
Kidney cancer (4)
Labor market (9)
Layoffs (153)
Leadership (4)
Legal (1709)
Liver cancer (35)
Lung cancer (139)
Lymphoma (63)
Machine learning (2)
Management (20)
Manufacturing (200)
MASH (28)
Medical device (5074)
Medtech (5077)
Mergers & acquisitions (8892)
Metabolic disorders (246)
Multiple sclerosis (32)
NASH (9)
Neurodegenerative disease (52)
Neuropsychiatric disorders (15)
Neuroscience (817)
NextGen: Class of 2025 (3231)
Non-profit (2450)
Now hiring (5)
Obesity (120)
Opinion (74)
Ovarian cancer (36)
Pain (36)
Pancreatic cancer (36)
Parkinson's disease (77)
Partnered (24)
Patents (85)
Patient recruitment (39)
Peanut (13)
People (24376)
Pharmaceutical (12)
Pharmacy benefit managers (1)
Phase I (7274)
Phase II (10055)
Phase III (7454)
Pipeline (670)
Policy (44)
Postmarket research (453)
Preclinical (2721)
Press Release (36)
Prostate cancer (54)
Psychedelics (6)
Radiopharmaceuticals (132)
Rare diseases (168)
Real estate (2425)
Recruiting (17)
Regulatory (7275)
Reports (10)
Research institute (1070)
Resumes & cover letters (46)
Rett syndrome (4)
RNA editing (4)
RSV (11)
Schizophrenia (30)
Series A (106)
Series B (66)
Service/supplier (3)
Sickle cell disease (25)
Special edition (3)
Spinal muscular atrophy (79)
Sponsored (13)
Startups (2432)
Stomach cancer (6)
Supply chain (44)
Tariffs (19)
The Weekly (12)
Vaccines (297)
Venture capitalists (31)
Weight loss (74)
Women's health (19)
Worklife (1)
Date
Today (77)
Last 7 days (340)
Last 30 days (1133)
Last 365 days (14289)
2025 (4726)
2024 (15490)
2023 (17768)
2022 (21635)
2021 (24213)
2020 (23565)
2019 (21350)
2018 (15865)
2017 (13187)
2016 (12034)
2015 (14235)
2014 (9767)
2013 (7362)
2012 (7751)
2011 (8071)
2010 (6937)
Location
Africa (261)
Alabama (40)
Alaska (7)
Arizona (69)
Arkansas (6)
Asia (17467)
Australia (2824)
California (2510)
Canada (884)
China (255)
Colorado (122)
Connecticut (134)
Delaware (73)
Europe (40967)
Florida (368)
Georgia (112)
Idaho (28)
Illinois (255)
India (15)
Indiana (114)
Iowa (6)
Japan (115)
Kansas (36)
Kentucky (9)
Louisiana (8)
Maine (47)
Maryland (422)
Massachusetts (1779)
Michigan (94)
Minnesota (157)
Mississippi (2)
Missouri (39)
Montana (13)
Nebraska (6)
Nevada (32)
New Hampshire (23)
New Jersey (703)
New Mexico (20)
New York (680)
North Carolina (441)
North Dakota (7)
Northern California (1074)
Ohio (89)
Oklahoma (8)
Oregon (13)
Pennsylvania (534)
Puerto Rico (2)
Rhode Island (13)
South America (359)
South Carolina (9)
South Dakota (1)
Southern California (940)
Tennessee (67)
Texas (376)
United States (9562)
Utah (81)
Virginia (71)
Washington D.C. (13)
Washington State (219)
West Virginia (3)
Wisconsin (30)
254,491 Results for "alta partners".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
VitriVax Receives Grant From the Coalition for Epidemic Preparedness Innovations (CEPI) to Leverage ALTA® Technology for Single-Dose Rabies Vaccine
April 29, 2025
·
2 min read
Press Releases
Alterome Doses First Patient in Phase 1 Study of ALTA3263, a Novel Pan-KRAS Dual ON/OFF Inhibitor, in Advanced Solid Tumors
March 10, 2025
·
3 min read
Press Releases
Alterome Therapeutics to Present Preclinical Data for its KRAS Selective Inhibitor ALTA3263 at the 2024 ENA Symposium
October 25, 2024
·
2 min read
Press Releases
Alterome Therapeutics Announces First Patient Dosed in Phase 1 Study of ALTA2618 in AKT1 E17K-mutant solid tumors (AKTive-001)
October 30, 2024
·
2 min read
Cardiovascular disease
Silence Quiets Phase III Pace for Lipoprotein Drug, Seeks Partner
The search for a partner for zerlasiran is ongoing, according to Silence. In the meantime, the biotech will focus its resources on divesiran, which it is testing for polycythemia vera and other hematologic indications.
February 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Sofinnova Partners and Gustave Roussy launch first biotech company through Strategic Partnership
March 18, 2025
·
4 min read
Press Releases
COMPASS SURGICAL PARTNERS NAMES MARK LANGSTON CHIEF DEVELOPMENT OFFICER
April 24, 2025
·
2 min read
Press Releases
Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.
April 2, 2025
·
2 min read
Press Releases
Baylor Genetics Joins Child Neurology Society as Official Genetic Testing Partner
April 29, 2025
·
3 min read
Press Releases
Celerius and Inquisite Partner to Accelerate Clinical Research with AI
April 22, 2025
·
1 min read
1 of 25,450
Next
